We are live on ! Find out more
SPIA

Steward Partners Investment Advisory Portfolio holdings

AUM $19.6B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+29.84%
3 Year Est. Return
+88.52%
5 Year Est. Return
+105.57%
10 Year Est. Return
AUM
$3.38B
AUM Growth
+$417M
Cap. Flow
+$208M
Cap. Flow %
6.13%
Top 10 Hldgs %
17.46%
Holding
2,893
New
105
Increased
917
Reduced
754
Closed
156

Sector Composition

Rank Sector Weight
1 Technology 10.09%
2 Financials 7.04%
3 Consumer Discretionary 6.34%
4 Healthcare 6.28%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
1951
Ligand Pharmaceuticals
LGND
$5.76B
$12K ﹤0.01%
192
+1
+0.5% +$67
NCV
1952
Virtus Convertible & Income Fund
NCV
$393M
$12K ﹤0.01%
542
+42
+8% +$951
NKTR icon
1953
Nektar Therapeutics
NKTR
$2.57B
$12K ﹤0.01%
40
OR icon
1954
OR Royalties Inc
OR
$6.31B
$12K ﹤0.01%
1,314
+637
+94% +$5.81K
REET icon
1955
iShares Global REIT ETF
REET
$5.08B
$12K ﹤0.01%
435
+5
+1% +$140
SSRM icon
1956
SSR Mining
SSRM
$6.49B
$12K ﹤0.01%
669
SSTI icon
1957
SoundThinking
SSTI
$107M
$12K ﹤0.01%
500
STAA icon
1958
STAAR Surgical
STAA
$1.27B
$12K ﹤0.01%
360
+35
+11% +$1.16K
TFI icon
1959
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.18B
$12K ﹤0.01%
+238
New +$12K
TRMB icon
1960
Trimble
TRMB
$13.4B
$12K ﹤0.01%
308
XOP icon
1961
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
$12K ﹤0.01%
130
-3,524
-96% -$305K
NVRO
1962
DELISTED
NEVRO CORP.
NVRO
$12K ﹤0.01%
105
CMD
1963
DELISTED
Cantel Medical Corporation
CMD
$12K ﹤0.01%
171
NBRV
1964
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$12K ﹤0.01%
38
+2
+6% +$917
BFYT
1965
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$12K ﹤0.01%
650
-250
-28% -$5.65K
AMCR icon
1966
Amcor
AMCR
$21.4B
$11K ﹤0.01%
204
EFOR
1967
Everforth Inc
EFOR
$1.34B
$11K ﹤0.01%
159
BAP icon
1968
Credicorp
BAP
$29.6B
$11K ﹤0.01%
54
-12
-18% -$2.52K
BXC icon
1969
BlueLinx
BXC
$701M
$11K ﹤0.01%
800
+550
+220% +$11.3K
CBT icon
1970
Cabot Corp
CBT
$4.46B
$11K ﹤0.01%
237
COLD icon
1971
Americold
COLD
$4.17B
$11K ﹤0.01%
+340
New +$12.5K
CWEN.A
1972
DELISTED
Clearway Energy Class A
CWEN.A
$11K ﹤0.01%
600
DCI icon
1973
Donaldson
DCI
$11.2B
$11K ﹤0.01%
198
EMLC icon
1974
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$11K ﹤0.01%
343
+3
+0.9% +$100
GEF icon
1975
Greif
GEF
$5B
$11K ﹤0.01%
250

Similar funds

Steward Partners Investment Advisory's Q4 2019 Portfolio in Review

As of Q4 2019, Steward Partners Investment Advisory held 2,893 positions worth $3.38B, up 14% from $2.97B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Steward Partners Investment Advisory deployed $208M of net new capital in Q4 2019, opening 105 new positions and adding to 917 existing holdings. Its largest new stake was Pacer Data & Infrastructure Real Estate ETF: 45,588 shares worth $1.49M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $8.59M trimmed.

  • Steward Partners Investment Advisory's largest Q4 2019 buy was Pacer Data & Infrastructure Real Estate ETF: 45,588 shares worth $1.49M.
  • Steward Partners Investment Advisory added most to Sun Communities in Q4 2019, an estimated $28.7M increase.
  • Steward Partners Investment Advisory's biggest Q4 2019 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $8.59M.
  • Steward Partners Investment Advisory fully exited Celgene Corp in Q4 2019, selling an estimated $1.85M.
  • Steward Partners Investment Advisory's ten largest holdings make up 17% of its $3.38B portfolio in Q4 2019.
  • Steward Partners Investment Advisory opened 105 new positions and closed 156 in Q4 2019.
  • Steward Partners Investment Advisory's portfolio value rose 14% quarter-over-quarter to $3.38B.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2019, filed 17 Jan 2020.